Orchestra BioMed Holdings, Inc. Ordinary Shares
OBIOOrchestra BioMed Holdings, Inc. is a medical device company focused on developing and commercializing innovative solutions for cardiovascular and other medical conditions. The company leverages a combination of proprietary technologies and strategic partnerships to bring minimally invasive and durable devices to market. Its portfolio includes products aimed at improving treatment outcomes and patient quality of life.
Company News
Orchestra BioMed initiated a pivotal U.S. clinical trial comparing its Virtue Sirolimus AngioInfusion Balloon to a paclitaxel-coated balloon for treating coronary in-stent restenosis, with 740 patients expected to be enrolled across 75 centers by mid-2027.
Orchestra BioMed Holdings, Inc. (OBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock...
The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy.
